FDA Inspection 1155320 — Novartis D.O.O.
The FDA completed an inspection of Novartis D.O.O. on Sep 11, 2020 in Menges. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 11, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Menges (Slovenia)
Additional details
Mutual Recognition Agreement (MRA)